Tatva Chintan Pharma IPO gets 4.5 times subscription

The preliminary public providing of Tatva Chintan Pharma Chem witnessed large investor curiosity, with the difficulty getting absolutely subscribed with hours of opening and at last closing with 4.51 occasions subscription on day 1 of subject on Friday.

The ₹500-crore IPO acquired bids for 1.47 crore shares as in comparison with 32.62 lakh shares on supply. The certified institutional consumers portionwas subscribed 50 per cent, whereas the non-institutional traders’ class acquired 1.14 occasions and people for retail traders 8.24 occasions, in response to NSE information.

The supply is in a value vary of ₹1,073-1,083 a share.


Inter Reviewed is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – The content will be deleted within 24 hours.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

eighteen − 9 =

Back to top button